Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.59 USD | +0.22% |
|
-0.22% | -2.34% |
27/06 | Guggenheim Initiates SOPHiA GENETICS at Buy With $6 Price Target | MT |
24/06 | Sophia Genetics S. A. Launches New Residual Acute Myeloid Application | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.34% | 30Cr | |
+20.35% | 3,32200Cr | |
+15.76% | 9.12TCr | |
+13.69% | 8.44TCr | |
+49.18% | 5.64TCr | |
-22.01% | 4.97TCr | |
+35.10% | 4.78TCr | |
-25.54% | 4.6TCr | |
+67.52% | 4.1TCr | |
-4.44% | 2.72TCr |
- Stock Market
- Equities
- SOPH Stock
- News SOPHiA GENETICS SA
- Morgan Stanley Adjusts Price Target on SOPHiA GENETICS to $12 From $13, Maintains Overweight Rating